Showing 2981-2990 of 9769 results for "".
Kaposi Sarcoma in HIV-negative Men: A Case Series
https://practicaldermatology.com/youngmd-connect/resident-resource-center/kaposi-sarcoma-in-hiv-negative-men-a-case-series/23158/What Does Efficacy Cost? Evidence for Relative Cost-Effectiveness of Biologic Therapies for Psoriasis
https://practicaldermatology.com/topics/psoriasis/what-does-efficacy-cost-evidence-for-relative-cost-effectiveness-of-biologic-therapies-for-psoriasis/23128/Despite high costs, evidence suggests that biologics are cost-effective options for moderate to severe psoriasis because of their efficacy.Teledermatology: The Present State of Dermatology's Future
https://practicaldermatology.com/topics/practice-management/teledermatology-the-present-state-of-dermatologys-future/21439/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-24/23525/SCALE Notes
https://practicaldermatology.com/issues/supplements/scale-notes-1/23043/News and views from Music City SCALEPatient-Centered Wound Healing
https://practicaldermatology.com/topics/feature/patient-centered-wound-healing/26645/Patient-Centered Wound HealingDERM2024 Meeting Wrap-Up
https://practicaldermatology.com/conferences/derm2024/derm2024-meeting-wrap/26974/DERM2024 Meeting Wrap-UpWhen Topicals Fail: The New IPC Consensus Every Clinician Should Know
https://practicaldermatology.com/programs/cme/when-topicals-fail-the-new-ipc-consensus-every-clinician-should-know/39967/Review IPC’s 2025 consensus guidance on reclassifying psoriasis severity and redefining failure of topical therapies.Exclusive: An Interview with Dr. Paola Pasquali
https://practicaldermatology.com/topics/general-topics/exclusive-interview-dr-paola-pasquali/26981/Exclusive: An Interview with Dr. Paola PasqualiUnleashing Revenue Growth:Harnessing Patient Data
https://practicaldermatology.com/topics/practice-management/unleashing-revenue-growth-harnessing-patient-data/26968/Unleashing Revenue Growth: Harnessing Patient Data